AZD-5069

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAZD-5069
Drug Alias NameAZD-5069
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsC-X-C motif chemokine receptor 2 antagonists
TargetsC-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2
Therapy Area/IndicationsRespiration DisordersPulmonary EmphysemaPulmonary Disease, Chronic Obstructive +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[18] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcMedimmune Llc
Inactive CompaniesThe Institute Of Cancer Research, London
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsRespiration DisordersPulmonary EmphysemaPulmonary Disease, Chronic Obstructive +[9] 

Other Information

ATC CodeN/A
Related LinksN/A